Redeemable Preferred Stock and Stockholders' Equity - Additional Information (Detail)
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
Jun. 27, 2022
USD ($)
$ / shares
shares
|
Sep. 28, 2020
$ / shares
|
Jul. 23, 2020
USD ($)
$ / shares
shares
|
Jun. 08, 2020
USD ($)
$ / shares
shares
|
Nov. 14, 2018
USD ($)
Customer
$ / shares
shares
|
Nov. 09, 2018
USD ($)
Customer
$ / shares
shares
|
Sep. 27, 2018
USD ($)
$ / shares
|
Mar. 06, 2018
USD ($)
$ / shares
|
Sep. 30, 2020
$ / shares
|
Aug. 31, 2020
$ / shares
|
Mar. 31, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
shares
|
Jun. 30, 2022
USD ($)
|
Jun. 30, 2020
$ / shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2021
USD ($)
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
|
Mar. 01, 2022
$ / shares
|
Feb. 28, 2021
USD ($)
|
Nov. 30, 2019
$ / shares
|
May 31, 2019
$ / shares
shares
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
180,000,000
|
|
|
|
180,000,000
|
|
180,000,000
|
|
|
|
|
|
Common stock, shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
7,144,000
|
|
|
|
7,144,000
|
|
7,142,000
|
|
|
|
|
|
Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
|
Series F Preferred stock, shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
0
|
|
|
|
|
|
Common stock value |
|
|
|
|
|
|
|
|
|
|
|
$ 7,000
|
|
|
|
$ 7,000
|
|
$ 6,000
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
6 years 1 month 6 days
|
|
|
|
6 years 1 month 6 days
|
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
111.00%
|
|
|
0.00%
|
111.00%
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
0.98%
|
|
|
0.00%
|
0.86%
|
|
|
|
|
|
|
Conversion of preferred stock into common stock | shares |
|
|
|
|
|
|
|
|
|
|
|
|
261
|
|
|
|
261
|
|
|
|
|
|
|
Common stock authorized for issuance | shares |
|
|
|
|
|
|
|
|
|
|
|
41,000,000
|
|
|
|
41,000,000
|
|
|
|
|
|
|
|
Compensation expense related to stock options |
|
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
$ 200,000
|
|
|
$ 1,700,000
|
$ 1,500,000
|
|
|
|
|
|
|
Total unrecognized compensation expense |
|
|
|
|
|
|
|
|
|
|
|
1,800,000
|
800,000
|
|
|
1,800,000
|
800,000
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
6,919,000
|
|
|
|
6,919,000
|
|
8,276,000
|
|
|
$ 600,000
|
|
|
Other liabilities |
|
|
|
|
|
|
|
|
|
|
|
260,000
|
|
|
|
$ 260,000
|
|
330,000
|
|
|
|
|
|
Unrecognized share based compensation expense to be recognized over weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 1 month 6 days
|
|
|
|
|
|
|
|
Allocated Share-based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
591,000
|
$ 192,000
|
|
|
$ 1,691,000
|
$ 1,488,000
|
|
|
|
|
|
|
Additional paid-in-capital |
|
|
|
|
|
|
|
|
|
|
|
$ 301,196,000
|
|
|
|
$ 301,196,000
|
|
$ 293,325,000
|
|
|
|
|
|
Other offering expenses |
|
|
|
$ 700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding stock options, RSUs and warrants excluded from diluted loss per share | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,600,000
|
1,000,000.0
|
|
|
|
|
|
|
Warrants adjusted exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.00
|
|
|
|
|
|
|
|
|
June 2022 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, shares | shares |
678,745,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering |
$ 6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
$ 4.625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 2022 Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity raise of gross proceeds |
$ 5,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
726,660,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
$ 4.624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 2020 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrants |
|
|
$ 15,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued in connection with debt instruments |
|
|
$ 15,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity, Fair Value Adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,500,000
|
|
|
|
|
Change in fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,800,000
|
|
|
|
|
Issuance costs for common stock warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,600,000
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15,300,000
|
|
|
|
|
|
|
|
July 2020 Warrants | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
45,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated to the warrants based upon fair values |
|
|
$ 15,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
Series F Convertible Preferred Stock and July 2020 Warrants | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 8.50
|
|
|
|
$ 8.50
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11.00
|
|
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109.80%
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.27%
|
|
|
|
|
|
|
|
Sale of common stock, shares | shares |
|
|
18,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend on convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,700,000
|
|
|
|
|
Series F Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity preferred stock, shares authorized | shares |
|
|
18,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price | $ / shares |
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series G Preferred stock, shares authorized | shares |
|
|
18,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted stock units outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
251,000
|
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
Series F Preferred Stock and July Two Thousand Twenty Amendment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
$ 5.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term (years) |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
$ 7.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility |
|
109.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
0.26%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series F Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock value |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrants |
|
|
2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds of common stock and warrants |
|
|
18,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued in connection with debt instruments |
|
|
2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend on convertible preferred stock |
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
$ 500,000
|
|
|
|
|
|
Convertible preferred stock, shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
Preferred stock par value | $ / shares |
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series F Convertible Preferred Stock | Rights Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds allocated to the warrants based upon fair values |
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series G Redeemable Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
|
10,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering, net of underwriting discounts and commissions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,600,000
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
$ 0.515
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity numbers of shares sold | shares |
|
|
|
10,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | June 2022 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
1,405,405,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement | Series F Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
652,500
|
|
|
|
652,500
|
|
|
|
|
|
|
|
Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration date |
|
|
|
Jun. 10, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from offering |
|
|
|
$ 6,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Combined purchase price of share and warrant | $ / shares |
|
|
|
$ 16.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary equity preferred stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
Series G Preferred stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
2002 Stock Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock authorized for issuance | shares |
|
|
|
|
|
|
|
|
|
|
|
124,400,000
|
|
|
|
124,400,000
|
|
|
|
|
|
|
|
Options available for future grants | shares |
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
2018 Long-Term Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock authorized for issuance | shares |
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
Options and restricted stock units outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
1,000,000.0
|
|
|
|
1,000,000.0
|
|
|
|
|
|
|
|
2018 Long-Term Incentive Plan | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock authorized for issuance | shares |
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted stock units outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
23,000,000
|
|
|
|
23,000,000
|
|
|
|
|
|
|
|
Phantom Share Units (PSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities |
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
$ 200,000
|
|
$ 300,000
|
|
|
|
|
|
Allocated Share-based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
Additional paid-in-capital |
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
100,000
|
|
$ 100,000
|
|
|
|
|
|
|
|
Shares issued in period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
400,000
|
|
|
|
|
|
Stock Appreciation Rights (SARs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
Allocated Share-based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
Additional paid-in-capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
Shares issued in period | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
|
|
Original Western Alliance Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price | $ / shares |
|
|
|
|
|
|
|
$ 58.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
$ 53.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
|
|
Sep. 27, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Original Western Alliance Warrant | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued to purchase shares of common stock equal value |
|
|
|
|
|
|
$ 120,000,000
|
$ 120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
|
|
|
372,023,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
$ 33.50
|
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
$ 25.00
|
|
Change in fair value of warrants |
|
|
|
|
|
$ 400,000
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants adjusted exercise price | $ / shares |
|
|
|
|
|
$ 9.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
|
|
|
|
|
|
|
|
487,198,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Number Of Trading Days | Customer |
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants Fair Value Assumptions Expected Term |
|
|
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
|
|
81.79%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
|
|
3.13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants adjusted strike price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 12.25
|
|
|
|
|
|
|
|
|
|
|
|
|
SWK Warrants | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 22.00
|
|
|
|
$ 22.00
|
|
|
|
|
|
|
|
SWK Warrants | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
33.50
|
|
|
|
$ 33.50
|
|
|
|
|
|
|
|
DPG Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,727,000
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
$ 33.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 54.25
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Change in fair value of warrants |
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expire date |
|
|
|
|
Nov. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
|
|
279,851,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number Of Trading Days | Customer |
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants Fair Value Assumptions Expected Term |
|
|
|
|
8 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, expected volatility rate |
|
|
|
|
8179.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions annual dividend per share | $ / shares |
|
|
|
|
$ 0.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants fair value assumptions, risk-free interest rate |
|
|
|
|
313.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finder's fee |
|
|
|
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
$ 15.50
|
$ 9.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DPG Warrants | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
35.50
|
|
|
|
$ 35.50
|
|
|
|
|
|
|
|
DPG Warrants | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
54.25
|
|
|
|
$ 54.25
|
|
|
|
|
|
|
|
June 2020 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued | shares |
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds of common stock and warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,200,000
|
|
|
|
|
|
|
|
Weighted average exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 10.5
|
|
|
|
$ 10.5
|
|
|
|
|
|
|
|
Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
Closing price of common stock | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.5
|
|
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109.80%
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.45%
|
|
|
|
|
|
|
|
Allocation to preferred stock and warrants before issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,000,000.0
|
|
|
|
|
|
|
|
Dividend Declared |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
Allocation to common stock and warrants before issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,900,000
|
|
|
|
|
|
|
|
June 2020 Warrants | Series F Convertible Preferred Stock and July 2020 Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Temporary Equity And Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant issued | shares |
|
|
45,000,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|